Chemotherapy followed by stem cell transplantation has fully halted clinical relapses and the development of new brain lesions in 23 of 24 patients with multiple sclerosis (MS) for a prolonged period without the need for ongoing medication. Results of Phase II trial published in The Lancet.

See the source article by following the link below:
Chemotherapy followed by stem cell transplantation has fully halted clinical relapses and the development of new brain lesions in 23 of 24 patients with multiple sclerosis (MS) for a prolonged period without the need for ongoing medication. Results of Phase II trial published in The Lancet.